Results 191 to 200 of about 407,106 (256)

Valuing Mortality Risk Reductions and Health Improvements: A Life Expectancy Framework to Harmonize Policy Traditions. [PDF]

Risk Anal
Nielsen JS, Chilton S, McDonald R.
europepmc   +1 more source

Engineering Resatorvid‐Loaded Sub‐Microgels of Epigallocatechin‐3‐gallate/Hyaluronic Acid to Treat Acute Lung Injury

Advanced Healthcare Materials, EarlyView.
This study presents HAEP@Res sub‐microgels as a lung‐targeted delivery system integrating antioxidant activity with anti‐inflammatory therapy. The sub‐microgels demonstrate excellent biocompatibility, efficiently scavenge intracellular ROS, and downregulate pro‐inflammatory cytokines and genes in a Bleo‐induced ALI mouse model. These findings highlight
Bo Liu, Olawale Alimi Alimi, Benjamin Stearnes, Svetlana Romanova, Brady J. Sillman, Mena Asha Krishnan, Kristina Bailey, Benson J. Edagwa, Huanhuan Joyce Chen, Han‐jun Wang, Bin Duan   +10 more
wiley   +1 more source

Health economics analysis of restrictive school smartphone policies in secondary schools in England (SMART Schools). [PDF]

BMJ Ment Health
Perry SJ, Goodyear VA, Pallan M, Adab P, Fenton S, Michail M, Patterson P, Randhawa A, Sitch AJ, Wade M, Al-Janabi H.   +10 more
europepmc   +1 more source

Cost-Effectiveness of the Support and Services at Home (SASH) Program for Cardiovascular Risk Factors: A Community-Based Approach to Healthy Aging in Place. [PDF]

Health Serv Res
Atherly A, Doerner C, Yan R, Schollmeyer J, Genge L, van den Broek-Altenburg E.   +5 more
europepmc   +1 more source

The Paradox of Life Extension with Traditional Cost-Effectiveness Analysis: A Case Study with Duchenne Muscular Dystrophy. [PDF]

J Health Econ Outcomes Res
Sedita L, Klimchak A, Perfetto E, Gooch K, Malone DC.   +4 more
europepmc   +1 more source

Cost-Effectiveness of Oral Immunotherapy Treatments vs No Treatment for Peanut Allergy in Children.

JAMA Netw Open
Huang L, Lloyd M, Franz A, Loke P, O'Sullivan M, Gold M, Quinn P, Tang MLK, Dalziel K.   +8 more
europepmc   +1 more source

Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension.

JAMA Dermatol
Augustin M, Feldman SR, Warren RB, Armstrong A, Vender R, López-Ferrer A, Dawe WH, Lambert J, Szilagyi B, Hoepken B, Warham R, Gottlieb AB.   +11 more
europepmc   +1 more source

Global Budget Revenue Model and Care for Patients Receiving Chemotherapy.

JAMA Netw Open
Lin YL, Herring B, Melamed A, Petrillo LA, Keating NL, Offodile AC.   +5 more
europepmc   +1 more source

Effect of Lung Cancer Screening, Smoking Cessation, and Cessation Smartphone App to Health-Related Quality of Life Among Heavy Smokers: Randomized Controlled Trial.

J Med Internet Res
Kurtti A, Iivanainen S, Kaarteenaho R, Andersen H, Jekunen A, Vasankari T, Koivunen J.   +6 more
europepmc   +1 more source